# ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026

- Source: PR Newswire
- Published: 2026-10-23T02:07:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/immunoforge-to-showcase-proprietary-platform-technologies-and-next-generation-oncology--phase-2-clinical-pipelines-at-bio-europe-2026-302917622.html
- Canonical: https://groundlevelnews.com/story/immunoforge-to-showcase-proprietary-platform-technologies-and-next-gen-f64ee2/

SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ -- ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases, today announced that its executive management team will participate...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._